Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06798389 · ClinicalTrials.gov registry record · NA
CMSL Ambulatory Sensitive Condition Nudge
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3,016
- Enrollment target
NCT06798389: Completed NA study, sponsored by Geisinger Clinic.
NCT06798389 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 3,016 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (115% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06798389, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,016 participants
- Enrollment target
Study Summary
The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where they received a diagnosis of an ambulatory sensitive condition (ASC). The evaluation will compare eligible patients with an ASC who were randomly assigned to receive follow-up outreach from a nurse (who was automatically prompted via the Epic electronic health record system to initiate outreach) with those who were randomly assigned to receive standard care. Analyses will be intent-to-treat. The primary outcome is ED use in the week following the appointment.
Primary Outcome
Does outreach decrease ED visits?
Interventions
- BEHAVIORAL Nurse Nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,016 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What the finished NCT06798389 record still lists
NCT06798389 is an interventional study that assigns participants to a tested intervention. Its 3,016 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (115% higher).
The record links to 0 conditions, and to 1 intervention - of which Nurse Nudge is the first listed.
NCT06798389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06798389 about?
NCT06798389 is a clinical study titled "CMSL Ambulatory Sensitive Condition Nudge". The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where they received a diagnosis of an ambu...
What is the current status of trial NCT06798389?
This trial is currently completed. It is a NA study. The enrollment target is 3,016 participants. The study started on 2025-01-06. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06798389?
The interventions under investigation include: Nurse Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT06798389?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06798389's enrollment target sits among peer trials
3,016 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI